Back
Bio-Rad Laboratories Vs. DXP Enterprises Industry Stock Comparison
Buy
58
BIO
Bio-Rad Laboratories
Last Price:
372.97
Seasonality Move:
7.32%
Buy
65
DXPE
DXP Enterprises
Last Price:
64.58
Seasonality Move:
39.89%
Buy
58
Bio-Rad Laboratories (BIO)
is a Buy
Is Bio-Rad Laboratories a Buy, Sell or Hold?
- The current Bio-Rad Laboratories [BIO] share price is $374.28. The Score for BIO is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy, Sell or Hold?
- The current DXP Enterprises [DXPE] share price is $61.59. The Score for DXPE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- DXPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIO Stock Price Chart
What is Bio-Rad Laboratories's stock price today?
-
The Bio-Rad Laboratories share price today is $374.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
DXPE Stock Price Chart
What is DXP Enterprises's stock price today?
-
The DXP Enterprises share price today is $61.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.63 | Buy |
| Relative Strength Index (14 RSI): | 69.11 | Buy |
| Chaikin Money Flow: | 137030 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (328.51 - 354.41) | Buy |
| Bollinger Bands (100): | (296.18 - 343.28) | Buy |
DXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 75.92 | Buy |
| Chaikin Money Flow: | 171896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49 - 54.5) | Buy |
| Bollinger Bands (100): | (47.11 - 53.29) | Buy |
BIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 347.61 | Buy |
| 20-day SMA: | 341.73 | Buy |
| 50-day SMA: | 335.19 | Buy |
| 200-day SMA: | 315.68 | Buy |
| 8-day EMA: | 355.25 | Buy |
| 20-day EMA: | 344.94 | Buy |
| 50-day EMA: | 335.5 | Buy |
| 200-day EMA: | 325.47 | Buy |
DXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.15 | Buy |
| 20-day SMA: | 51.64 | Buy |
| 50-day SMA: | 51.78 | Buy |
| 200-day SMA: | 47.83 | Buy |
| 8-day EMA: | 52.64 | Buy |
| 20-day EMA: | 51.7 | Buy |
| 50-day EMA: | 51.38 | Buy |
| 200-day EMA: | 47.37 | Buy |
Bio-Rad Laboratories Earnings Growth & BIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.76 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.49 per share, and an increase next year of $1.42 per share.
DXP Enterprises Earnings Growth & DXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.30 per share.
Bio-Rad Laboratories Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
DXP Enterprises Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||